Analgesic Efficacy of Nephrostomy Tract inFiltration of Bupivacaine and Ketamine after Tubeless Percutaneous Nephrolithotomy: A Prospective Randomized Trial

Abstract:
Objectives
The aim of the present study was to assess the analgesic efficacy of IV ketamine injection inaddition to nephrostomy tract infiltration of ketamine – bupivacaine on postoperative pain relief after tubeless percutaneous nephrolithotomy (PCNL).
Patients and
Methods
Patients (n = 100), with renal stone who were candidates for PCNL were randomized to five groups with 20 cases in each: Group C, 10 mL of saline solution was infiltrated into the nephrostomy tract; Group B, 10 ml of 0.25% bupivacaine was infiltrated into the nephrostomy tract; Group BK1, 10 ml of 0.25% bupivacaine plus 0.5mg/kg ketamine was infiltrated into the nephrostomy tract; Group BK2, 10 ml of 0.25% bupivacaine plus 1.5mg/kg ketamine was infiltrated into the nephrostomy tract; Group K, 10 ml of saline solution containing 0.5mg/kg ketamine was intravenously administered. Post-operative pain scores were compared between groups as the primary objective. Comparison of Sedation Scores, rescue analgesic consumption, time to the first rescue analgesics administration, hemodynamic and SpO2 values were regarded as the secondary objective.
Results
Mean VAS scores in the first 30 minutes and total analgesic consumption in the first 24 hours of post-operative period were significantly lower in groups BK1 and BK2 in comparison with the other groups (P
Conclusions
Infiltration of ketamine plus bupivacaine provides superior analgesic effects in PCNL surgery compared with other methods.
Language:
English
Published:
Iranian Journal of Pharmaceutical Research, Volume:15 Issue: 2, Spring 2016
Pages:
619 to 626
magiran.com/p1549307  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!